Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B (Q71961886)
Jump to navigation
Jump to search
scientific article published on 01 August 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B |
scientific article published on 01 August 1995 |
Statements
Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B (English)
J. E. Herndon
D. R. Hollis
J. Ellerton
A. Langleben
F. Richards